Confirmation of lung adenocarcinoma as the primary cancer with detection of EML4-ALK rearrangement using next-generation sequencing: a case study
This study suggested that NGS be recommended to detect ALK rearrangement in the patients with carcinoma of unknown primary site, and that resistance to targeted therapy with ALK inhibitors should be considered for personalized precision medicine.PMID:36099717 | DOI:10.1016/j.prp.2022.154105
Source: Pathology, Research and Practice - Category: Pathology Authors: Yijun Mo Lina Lin Jianhua Zhang Yan Zhong Tao Zhang Chenghua Zhong Jun Yan Jun Kuang Quanwei Guo Jianfeng Tan Dongfang Li Mengxi Wu Source Type: research
More News: Adenocarcinoma | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Carcinoma of Unknown Primary | Gastric (Stomach) Cancer | Lymphoma | Men | Ovaries | Pathology | Study